132 followers
In both 2013 & 2019, there was a showdown between the defending champion, Humira (adalimumab), versus the challenger, Actemra (tocilizumab), for treating rheumatoid arthritis. Who won? https://t.co/tT2R1HHjOA https://t.co/vFcULQrubZ https://t.co/FZf3uP